论文部分内容阅读
MSII组23例,采用诺和锐(门冬氨酸胰岛素)分别于鼻饲前1min皮下注射;诺和灵N每晚10对皮下注射。CSII组23例采用诺和锐放置于韩国DANA胰岛素泵内,将胰岛素持续缓慢皮下注射。结果CSII组血糖控制达标时间、胰岛紊用量少于MSII组(P<0.01);平均低血糖发生次数低于MSⅡ组(P<0.05)。术后切口感染率低于MSII组。结论CSII比MSII更适合用于急诊颅脑术后处于昏迷期的糖尿病患者。
In the MSII group, 23 patients were injected subcutaneously with Connaught Rui (Aspartate Insulin) 1 min before nasal feeding, and Concomitant Noravine N 10 subcutaneous injection every night. In the CSII group, 23 patients were placed in South Korea DANA insulin pump using Novo and Rui and insulin was slowly and subcutaneously injected. Results The blood glucose control time of CSII group was less than that of MSII group (P <0.01). The average number of hypoglycemia was lower than that of MSⅡ group (P <0.05). Postoperative incision infection rate was lower than MSII group. Conclusion CSII is more suitable than MSII for diabetics who are in coma after craniocerebral surgery.